PHOTO
Dubai– Mediclinic Welcare Hospital has officially introduced their new JCI-accredited Diabetes Clinical Care Programme, the first of its kind in Dubai.
Diabetes is a chronic illness that is not only detrimental to an individual’s health, but places a heavy burden on the healthcare system. The management of diabetes often requires continuous medical care from an experienced team to prevent acute and long term complications.
Mediclinic Welcare Hospital has recognised the importance of delivering quality holistic care to diabetes patients, whose medical needs are beyond the scope of an individual practitioner. Their newly JCI-accredited programme offers care from a multidisciplinary team of experts, including endocrinologists, nutritionists and diabetes educators. Following the well-defined and respected standards of medical practice guidelines, registered programme members will have agreed goals set by the team, which will be measured at specific intervals in accordance with the patients’ individual needs, rights and confidentiality.
Dr. Ibtisam Alhaj, Quality and Patient Safety Officer at Mediclinic Welcare Hospital, explains the importance of the programme being JCI-accredited and what that means for the patients:
“The clinical care diabetes programme certification is awarded by the Joint Commission International. JCI is an international organisation that looks at the quality of medical care, and determines parameters that measure quality. By receiving this certification, our patients can rest assured that they will be offered the highest quality collaborative and comprehensive care for their diabetes at Mediclinic Welcare Hospital.
Our programme aims to take care of patients from A-Z by providing a clear understanding of diabetes, nutrition and dietary guidance, tips on healthy lifestyle, blood glucose monitoring, appropriate medication management and regular follow up.”
For more information about the programme and how to become a part of it, please call 800 1999.
© Press Release 2021
Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.
The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.
To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.
